Giant Biogene Holding Co., Ltd. (HKG:2367)

Market Cap	76.93B
Revenue (ttm)	5.89B
Net Income (ttm)	2.19B
Shares Out	1.02B
EPS (ttm)	2.19
PE Ratio	34.51
Forward PE	28.23
Dividend	1.27 (1.65%)
Ex-Dividend Date	Jun 17, 2025

Volume	7,174,335
Average Volume	11,900,320
Open	74.95
Previous Close	75.65
Day's Range	74.95 - 79.25
52-Week Range	35.00 - 80.80
Beta	0.79
RSI	62.52
Earnings Date	Mar 26, 2025

About Giant Biogene Holding

Giant Biogene Holding Co., Ltd., an investment holding company, engages in the research, development, manufacture, and sale of bioactive material-based beauty and health products in the People’s Republic of China. It also manufactures rare ginsenosides technology-based functional foods; and offers medical devices. The company offers its functional skincare products, medical dressings, and functional foods primarily under the Comfy, Collgene, Keyu, and SKIGIN brands. Giant Biogene Holding Co., Ltd. was founded in 2000 and is headquartered in Xi'...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 2000
• Employees: 1,758
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2367

Financial Performance

In 2024, Giant Biogene Holding's revenue was 5.54 billion, an increase of 57.17% compared to the previous year's 3.52 billion. Earnings were 2.06 billion, an increase of 42.06%.

Financial numbers in CNY